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Abstract 
 
Sina was found as the factor which causes a small eye phenotype of Drosophila. Xenopus 
Siah2 (xSiah2) was isolated, and it was overexpressed during the development of Xenopus 
laevis, resulting in the formation of a small eye phenotype. The small eyes are characterized by 
a reduced size of the lens. Two highly conserved human homologs of Drosophila Sina, termed 
Siah1 and Siah2, were characterized. Siah2 regulates the stability of prolyl hydroxylase 
domain (PHD), with a concomitant effect on hypoxia inducible factor-1 (HIF-1α) availability 
in the hypoxia response pathway. Hypoxia is an important physiological condition during 
embryonic development. The hypoxia response pathway contributes to eye development 
during the embryonic development of Xenopus laevis, however, the role of Siah2 in eye 
development of Xenopus laevis embryos remains unknown. In Chapter I, the role of 
Siah2-mediated hypoxia response pathway in eye development was characterized. Xenopus 
Siah2 (xSiah2) mRNA was detected in lens tissue and xSiah2 overexpression caused a 
thickened lens placode, leading to loss of the optic lens. xSiah2 overexpression increased 
Xenopus HIF-1α (xHIF-1α) accumulation. xHIF-1α degeneration with HIF-1 inhibitor 
restored the optical abnormality, suggesting that the xSiah2-induced HIF-1abundance causes 
abnormal lens phenotype. Additionally, Nrf2 protein was suppressed by hypoxia, and the 
suppression of Nrf2 under hypoxia was restored by the proteasome inhibitor, suggesting that 
some unidentified hypoxia-activated E3 ubiquitin ligase may be involved in the degradation of 
Nrf2. In Chapter II, I described the mechanism related to degradation of Nrf2 under hypoxia. 
Inhibition or knockdown of Siah2 prevented the suppression of Nrf2. Moreover, Siah2 
interacted with Nrf2 through a binding motif, suggesting that Siah2 contributes to the 
suppression of Nrf2. Some cytosolic kinases also play important roles in Nrf2 regulation. 
Though PKC phosphorylates serine residues of Nrf2 during hypoxia, knockdown of Siah2 
rescued hypoxic decreases in an Nrf2 mutant that mimicked phosphorylation at serine 40 or 
lacked this phosphorylation site, suggesting that Siah2 contributes to the degradation of Nrf2 
irrespective of its phosphorylation status. 
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General Introduction 
 
The RING finger ubiquitin ligase seven in absentia (Sina) was found as the factor which 
causes a small eye phenotype of Drosophila melanogaster, and the protein is localized in the 
nuclei of several precursor cells including R7 (1). Studies on the development of Drosophila R7 
photoreceptor have illustrated the mechanisms how signal transduction events are involved in 
the regulation of cell fate in a multicellular organization. 
Xenopus Siah2 (xSiah2), a protein with 67% amino acid identity to Drosophila Sina, was 
isolated. The occurrence of xSiah2 is restricted to the brain, spinal cord and eyes. The function 
of the Siah protein in the process of development of vertebrates has remained unknown. To 
demonstrate whether or not the vertebrate factor participates in the process of eye formation, 
xSiah2 was overexpressed during the development of Xenopus laevis, and the displayed result 
the formation of a small eye phenotype. The vertebrate counterpart of a C-terminal loss of 
function Sina mutant, which caused a deficiency of the R7 photoreceptor cells in Drosophila, 
also induced smaller eyes phenotype in Xenopus Laevis. The small eyes were characterized by a 
reduced size of the lens, the retina and the pigmented epithelium (2). 
Two highly conserved human homologs of Drosophila Sina, termed Siah1 and Siah2, were 
characterized. Siah1 encodes a 282 amino acid protein with 76% identity to the Drosophila Sina 
protein. Siah2 encodes a 324 amino acid protein with 68% identity to the Drosophila Sina and 
77% identity to human Siah1 (3). Both Siah1 and Siah2 are expressed in many normal and 
cancer tissues, and there are only subtle differences between their expressions. While Sina is a 
nuclear localized protein, both Siah1 and Siah2 are expressed in the cytoplasm of mammalian 
cells (4). 
Hypoxia-inducible factor-1 (HIF-1) is a central transcription factor of the cellular response 
to hypoxia (5). HIF-1 is regulated by the hydroxylation of its proline residues. Prolyl 
hydroxylase domains (PHDs) play a central role in this mechanism (6). The availability of PHD 
is regulated via its targeting for proteasome-dependent degradation by the E3 ubiquitin ligase 
Siah2 under hypoxia (7). 
Hypoxia is an important physiological condition during embryonic development. In the 
previous study, overexpression of xSiah2 caused a small eye phenotype of Xenopus laevis. 
Additional overexpression of PHD rescued the abnormal lens formation caused by xSiah2, 
suggesting that the level of expression or activity of PHD proteins is important to the 
maintenance of homeostasis in the embryonic development (8). In chapter I, I investigated the 
mechanism by which xSiah2 overexpression caused a small eye phenotype of Xenopus laevis.  
Additionally, NF-E2-related factor 2 (Nrf2) protein, which acts as a key regulator of cellular 
oxidative stress, was suppressed by hypoxia, and the suppression of Nrf2 under hypoxia was 
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restored by the proteasome inhibitor, suggesting that some unidentified hypoxia-activated E3 
ubiquitin ligase may be involved in the degradation of Nrf2. Siah2 is known to be an important 
regulator of hypoxia-activated pathways and is also involved in the degradation of some 
substrates through the E3 ubiquitin ligase and proteasome pathways (9). Additionally, Siah2 
directly binds to substrates carrying the AXVXP binding motif (10). Interestingly, I found a 
putative Siah2-binding motif, AQVAP, at position 170–174 in Nrf2. In Chapter II, I 
investigated whether or not Siah2 is involved in the mechanism for hypoxic suppression of 
Nrf2. 
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CHAPTER I 
 
Siah2 causes a small eye phenotype  
by degradation of PHD. 
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I.1 Introduction 
 
Siah2 was identified in the R7 photoreceptor cells of Drosophila melanogaster (1). Siah2 
functions to target diverse protein substrates for degeneration via ubiquitination. In the hypoxia 
response pathway, Siah2 mediates efficient ubiquitination to regulate the stability of prolyl 
hydroxylase (PHD) (7). The mammalian genome encodes three closely related PHD proteins, 
designed as PHD1, PHD2, and PHD3. PHD3 interacts with either PHD1 or PHD2, leading to 
the formation of PHD complexes. Tight regulation of the PHD complex activity and stability 
affects the availability of hypoxia inducible factor-1α (HIF-1α) (11). PHD proteins require 
molecular oxygen to hydroxylate HIF-1α, which in turn becomes a signal for the degeneration 
of HIF-1α via interaction with the von Hippel-Lindau tumor suppressor protein (pVHL) 
ubiquitin ligase complex (12). Available HIF-1α, after the interaction with HIF-1β (13), is a 
transcription factor responsible for the expression of target genes such as vascular endothelial 
growth factor (VEGF) gene (14). 
The possible involvement of the hypoxia response pathway in the neurogenesis of vertebrates 
such as mice and frogs has recently been reported. HIF-1α knockout mice show defective 
angiogenesis as well as abnormal neurogenesis. Overexpression of Xenopus Siah2 (xSiah2) in 
Xenopus laevis causes the small eye phenotype (8). This optical abnormality apparently results 
from a deficient lens. 
Lens tissue is formed during the neurula and tailbud stages of Xenopus development. There 
are four phases of lens formation: (Phase 1) Presumptive lens ectoderm (PLE) is formed in the 
surficial layer of the embryo during the neurula stages; (Phase 2) interaction between the PLE 
and anterior neural tube results in PLE thickening and development into a lens placode during 
the early tailbud stage; (Phase 3) the lens placode invaginates and develops into a vesicle 
through the endothelial mesenchymal transition (EMT): and (Phase 4) differentiation into 
cellular layers occurs (15). 
Previously two Xenopus PHD (xPHD) proteins, xPHD45 and xPHD28 were isolated, and 
characterized during the embryonic development of Xenopus Laevis (8). In the embryonic 
development, the co-injection with xPHD28 mRNA restores the small eye phenotype caused by 
xSiah2 overexpression, suggesting that xSiah2 contributes to eye development via xPHD. 
However, the function of the hypoxia response pathway in embryonic sensory organogenesis, 
including the lens, remains unclear. Given the importance of xSiah2 in the stability of xPHD 
and consequent Xenopus HIF-1α (xHIF-1α) levels, I asked whether the hypoxia response 
pathway plays a potential role in lens formation. 
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I.2 Materials and methods 
 
Chemicals and antibodies 
Resveratrol was purchased from Sigma (St Louis, MO); MMLV reverse transcriptase from 
Fermentas (Burlington, Canada); KOD plus DNA polymerase from TOYOBO (Tokyo, Japan); 
and T3, T7, and SP6 RNA polymerases and Go taq polymerase from Promega (Madison, WI). 
Antihuman -actin antibody was purchased from Sigma and horseradish peroxidase-conjugated 
antirabbit IgG antibody was purchased from Bio-Rad (Hercules, CA). Antixenopus Siah2 
antibody was prepared as follows. The first half of xSiah2 was ligated into pQE80L vector 
(QIAGEN, Hilden, Germany), which allows protein expression in Escherichia coli (E.coli.) 
strains. xSiah2 peptide were then expressed in E.coli. DH5α and purified using Ni-NTA agarose 
(QIAGEN). Antibodies were then raised against human PHD3, xSiah2, and human HIF-1α in 
rabbits using a previous described method (8,16). Reaction of the antihuman PHD3, HIF-1α and 
β-actin antibodies with xPHD, xHIF-1α and Xenopus β-actin, respectively, was confirmed. All 
experiments were conducted in accordance with guidelines on the welfare of experimental 
animals and with the approval of the Ethics Committee on the use of animals of Kwansei 
Gakuin University. 
 
Isolation of RNA and RT-PCR analysis 
Total RNA extracted from 5 embryos was prepared with Isogen (Nippon gene, Toyama, 
Japan) according to the manufacturer’s instructions. After dissolving or homogenizing samples 
with ISOGEN, chloroform was added to the mixture and centrifuged. The homogenate was 
separated into three phases. The aqueous phase was collected. cDNA was synthesized using 
total RNA (1 µg) in a total volume of 10 µL with Moloney Murine Luekemia Virus (MMLV) 
reverse transcriptase according to the manufacturer’s instructions as follows: incubation at 25 ˚C 
for 15 min and at 42 ˚C for 60 min followed by heating at 70 ˚C for 10 min. Polymerase chain 
reaction (PCR) was performed at 94 ˚C for 2 min and then for a particular number of cycles of 
94 ˚C for 30 s, 55 ˚C for 30 s, and 72 ˚C for 30 s in a reaction mixture containing 10 pmol of 
each primer, Go taq polymerase, and cDNA (100 ng). Primers, GenBank accession numbers, 
cycles, and sequences for PCR are shown in Table I. The PCR products were separated by 
electrophoresis on a 1% agarose gel, visualized with ethidium bromide staining, and quantified 
by scanning densitometry using ImageJ software (version 1.36b; National Institutes of Health, 
Bethesda, MD). The relative mRNA transcript levels were normalized by Histone H4 (Genbank: 
M21286). 
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Isolation of xSiah2   
cDNA of xSiah2 (GenBank: AF155509) was amplified by PCR. Thirty-five cycles of PCR 
(94°C for 30 s, 57°C for 30 s, and 68°C for 90 s) were performed using the cDNA obtained 
from reverse transcription of total RNA from embryos as the template, KOD plus DNA 
polymerase and corresponding primer pairs. Primer pairs shown in Table II a primers 1 and 2 for 
xSiah2/pBluescriptII+ (pBS), primers 3 and 4 for xSiah2/pCS2+, and primers 3 and 5 for 
xSiah2/pQE80L. The cDNA of xSiah2 was digested with BamHI and SpeI, BamHI and EcoRI, 
or BamHI and HindIII and then ligated into pBS (Agilent Technologies, Santa Clara, CA), 
pCS2+ (RZPD, Berlin, Germany), or pQE80L (Qiagen, Valencia, CA), respectively. 
 
Capped mRNA synthesis and micro-injection 
GFP and xSiah2 mRNAs were prepared from GFP/pCS2+ and xSiah2/pCS2+, respectively. 
After the plasmids were linearized with the restriction enzyme NotI, capped mRNAs were 
synthesized using a mCAP RNA synthesis kit (Promega) according to the manufacturer’s 
instructions. Synthesized mRNAs (total 2ng/cell) were injected into each dorsal blastomere at 
the two-cell stage. 
 
Eggs and embryos of Xenopus laevis 
Unfertilized eggs of wild type and albino Xenopus laevis (Watanabe Zoushoku, Hyogo, 
Japan) were obtained by injecting a female with 120 units of human chorionic gonadotropin 
(Kowa, Tokyo, Japan). The eggs were fertilized with the chestnuts suspended in 1.0×Modified 
Birth’s Solution (MBS) containing 0.5 mM HEPES (pH 7.5), 10 mM NaCl, 0.2 mM KCl, 0.1 
mM MgCl2, and 0.2 mM CaCl2. The chestnuts were surgically isolated from a male. The 
fertilized embryos were dejellied with 1% sodium thioglycollate and washed with 0.1×MBS 
several times. The developmental stage of embryos was determined according to Nieuwkoop 
and Faber’s normal table of Xenopus laevis (17). 
 
Whole mount in situ hybridization 
Thirty albino embryos were fixed in fully dehydrated ethanol. Sense and antisense probes for 
xSiah2 were prepared from xSiah2/pBS and then linearized with SpeI or BamHI, respectively, 
and transcribed with T3 or T7 RNA polymerase, respectively, in the presence of digoxygenin 
UTP (Roche). Hybridized probes were visualized according to the Roche DIG protocol with a 
minor alteration that 0.45 mL of nitro-blue tetrazolium chloride (NBT) (75 mg/mL in dimethyl 
formamide) and 3.5 mL of 5-bromo-4-chloro-3’-indolylphosphatase p-toluidine salt (BCIP) 
(Roche) were added to 1 mL of alkaline phosphatase buffer containing 100 mM Tris-HCl (pH 
9.5), 100 mM NaCl, 50 mM MgSO4, 0.1% Tween 20, and 25 mM levamisole. 
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Western blotting 
Twenty embryos were homogenized in buffer containing 50 mM Tris-HCl (pH 7.4), 1mM 
EDTA, 1 mM dithiothreitol (DTT), 150 mM KCl, and 100 mM phenylmethylsulfonyl fluoride 
(PMSF), and then solubilized with sodium dodecylsulfate (SDS). The resulting solution was 
subjected to SDS–polyacrylamide gel electrophoresis. Proteins were blotted onto a 
nitrocellulose membrane and reacted with antibodies against human β-actin, human HIF-1α, 
human PHD, and xSiah2. 
 
Histological analysis 
Twenty embryos were fixed in fully dehydrated ethanol and embedded in paraffin. Sagittal 
sections were cut 10 µm thick and stained with hematoxylin and eosin. 
 
Statistical analysis 
All data are reported as mean ± SD. Statistical analysis of the data was performed by one-way 
ANOVA. Significance was determined by ANOVA followed by Fisher’s protected least 
significant difference. 
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I.3 Results 
 
Localization of xSiah2 mRNA during development of Xenopus laevis 
The previous study suggested that Siah2 contributes to eye formation, which initiates at st. 24 
during the development of Xenopus laevis (17). Hence, albino embryos of Xenopus laevis were 
grown until st. 24 (early tailbud stage), 30 (middle tailbud stage), and 38 (later tailbud stage) 
and harvested at each stage. The accumulation pattern of xSiah2 mRNA in these embryos was 
investigated by whole in situ hybridization (Fig. I-1A-G). xSiah2 mRNA was not detected 
anywhere at st. 24 (Fig. I-1D), and was detected in the lens placode at st. 30 (Fig. I-1E) and 38 
(Figs. I-1F and 1G). Accordingly, we focused on the role of Siah2 in lens formation during 
development of Xenopus laevis. 
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Contribution of xSiah2 to lens formation 
At the two-cell stage, xSiah2 mRNA was injected into either one dorsal blastomere (S1 
treatment group) or both dorsal blastomeres (S2 treatment group). The effect of xSiah2 
overexpression on the level of xPHD and xHIF-1α accumulations at st. 30 and 38 was then 
investigated by western blotting (Fig. I-2A). In the S2 treatment group, the level of xSiah2 and 
xHIF-1α proteins was significantly increased at st. 30 and 38; xPHD was conversely decreased, 
suggesting that xSiah2 overexpression induced the degeneration of xPHD with concomitant 
effect on the enrichment of available xHIF-1α. 
Next, to investigate the effect of xSiah2 overexpression on lens formation, the organogenesis 
of eyes in Xenopus laevis embryos was observed (Fig. I-2B, left side). GFP or xSiah2 mRNA 
was injected into each dorsal blastomere at the two-cell stage, and the embryos were harvested 
at st. 30. The side of embryo injected with GFP mRNA developed a normal dorsal head region 
phenotype. On the side of the embryos injected with xSiah2 mRNA, a thickened lens ectoderm 
was observed. Next, these embryos were grown to st. 38 and then harvested for histological 
analysis (Fig. I-2B, right side). While the side of embryo injected with GFP mRNA had normal 
eyes, the side injected with xSiah2 mRNA demonstrated loss of the lens as well as thickened 
lens ectoderm. 
Next, xSiah2 mRNA was injected into both dorsal blastomeres at the two-cell stage, and the 
effect of xSiah2 overexpression on the transcriptional levels of the lens marker genes, FoxE3 
(Genbank: BC169818) and β-crystallin (Genbank: BC084735) mRNAs, at st. 30 and 38 were 
then investigated by RT-PCR (Fig. I-2C). FoxE3 represses differentiation in the undifferentiated 
lens ectoderm, and β-crystallin is expressed in the differentiated lens ectoderm (18). While the 
transcriptional level of FoxE3 mRNA was not affected by xSiah2 overexpression at st. 24, it 
was decreased at st. 30 and 38. The transcriptional level of β-crystallin mRNA was decreased at 
all stages, indicating that xSiah2 contributes to lens formation and, in particular, to the 
differentiation of lens endothelial cells. 
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Contribution of the Siah2-mediated hypoxia response pathway to lens formation 
Siah2 functions to target diverse protein substrates for degeneration via ubiquitination. It was 
previously found that co-injection with xPHD restores the optical abnormalities caused by 
xSiah2 overexpression. This suggests that xPHD is a target substrate of xSiah2 during eye 
development. Accordingly, the role of xSiah2-mediated hypoxia response pathway in lens 
formation was investigated. GFP or xSiah2 mRNA was injected into both dorsal blastomeres of 
embryos at the two-cell stage; xSiah2 mRNA-injected embryos were then exposed to resveratrol, 
an inhibitor of HIF-1α (19). Embryos were treated with resveratrol from st. 12 to 38 in R1 
treatment group, and from st. 22 to 38 in R2 treatment group. The level of xHIF-1α at st. 30 or 
38 in each treatment group was investigated in these embryos by western blotting (Fig. I-3A). 
Treatment with resveratrol from st. 12 to 38 restored xHIF-1α expression to normal at st. 30. 
Exposure to resveratrol from st. 22 to 38 did not affect the level of xHIF-1α expression at st. 30 
or st. 38. Next, the organogenesis of the eyes was evaluated in these groups (Fig. I-3B). The 
percentage of embryos with optical malformations caused by xSiah2 mRNA injection was 
reduced by treatment with resveratrol from st.12 to 38, but not from st.22 to 38, suggesting that 
xSiah2 may contribute to lens formation via xHIF-1α. 
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Disruption of the Notch signaling pathway by Siah2 overexpression 
An EMT process is involved in the initial step of lens vesicle formation (20). The EMT 
converts epithelial cells with a nonmotile morphology into migratory cells that can invade other 
tissues. The EMT is accompanied by changes in the expression of specific genes, such as 
Snail-1 and N-cadherin (21,22). Snail-1 functions to induce N-cadherin mRNA transcription 
during the EMT of endothelial cells. Both Snail-1 and ESR-1 mRNAs are downstream factors in 
Notch signaling (21,23). To investigate the effect of xSiah2 overexpression on the EMT, the 
transcriptional levels of the EMT-related genes, N-cadherin (Genbank: X57675), Snail-1 
(Genbank: BC056857), and ESR-1 (Genbank: AF383157) were investigated at st. 30 using 
RT-PCR (Figs. I-4A and 4B). XSiah2 overexpression repressed expression of all the 
EMT-related genes, Snail-1, N-cadherin, (Fig. I-4A) and ESR-1 (Fig. I-4B) at st. 30. These 
results indicate that xSiah2 overexpression inhibited the activity of Notch signaling, leading to 
EMT-mediated lens vesicle formation. 
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I.4 Discussion 
 
xSiah2 mRNA was not detected during the development of the PLE into the lens placode but 
was detected while the lens placode was invaginating and differentiating. This result suggests 
that xSiah2 participates in lens vesicle formation and/or differentiation into cellular layers rather 
than PLE formation and thickening of the lens placode. FoxE3 functions to thicken the lens 
placode; however, xSiah2 overexpression did not affect the transcription of FoxE3 mRNA at st. 
24, and also, xSiah2 mRNA was not detected anywhere at st. 24, thereby strongly confirming 
that xSiah2 did not participate in the thickening of the lens placode. XSiah2 overexpression 
causes thickening of lens ectoderm even at st.30. This morphological difference is probably due 
to defective invagination of the lens vesicle caused by xSiah2 overexpression, indicating that 
xSiah2 contributes to the invagination of the lens vesicle rather than the differentiation of the 
cellular layers. 
XSiah2 overexpression repressed xPHD expression. In addition, xPHD overexpression by 
co-injection with xSiah2 restored the absence of lens formation caused by xSiah2 
overexpression, suggesting that xPHD is the substrate of xSiah2 and that xSiah2 participates in 
lens formation via xPHD in vivo. In the Xenopus hypoxic response pathway in lens endothelial 
cells, xPHD interacts with another xPHD, which could be xPHD1. The Xenopus homolog of 
human PHD2 is known, but this is unlikely to be involved in lens formation as it is not found in 
the lens region (data not shown). At low oxygen concentrations in vitro, PHDs exhibit 10% and 
50% of their maximum hydroxylase activity toward their substrates, including HIF-1α (24). 
During lens vesicle formation, the active degeneration of xPHDs by xSiah2 induced the 
suppression of xPHD hydroxylase activity more efficiently than that by regulation of oxygen 
alone. The optical malformation was again seen when the xHIF-1α overexpression induced by 
xSiah2 injection was reversed by resveratrol treatment at st. 30 but not at st. 38. This result 
suggests that xSiah2 participates in lens formation via xHIF-1α at st. 30, when the lens vesicle is 
being formed, indicating that xSiah2 participates in lens vesicle formation via xHIF-1α. 
In this study, xSiah2 overexpression caused a decrease in the expression of EMT-related 
genes such as Snail-1, N-cadherin and ESR-1. This result suggests that the disruption of EMT 
by xSiah2 overexpression inhibited lens vesicle formation, leading to the lens defect. The 
xSiah2-mediated hypoxia response pathway thus participates in the EMT. Snail-1, ESR-1 and 
FoxE3 are directly up-regulated by Notch signaling. However, xSiah2 overexpression 
suppressed the transcription of Snail-1 and ESR-1 mRNAs at st. 30, but not that of FoxE3 
mRNA at st. 24. Notch signaling is the communication system between cells. During lens 
formation, some Notch signaling pathways are activated independently. Between retinal 
progenitor cells in the optic cup and lens epithelial cells, Notch ligands interact with the Notch 
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receptor. This interaction is necessary for the transcription of FoxE3 mRNA in lens epithelial 
cells, which maintains the undifferentiated state, and is located in the embryonic surface 
ectoderm, leading to the induction of PLE thickening. xSiah2 overexpression did not alter the 
transcription of FoxE3 mRNA at st. 24, suggesting that xSiah2 did not affect Notch signaling 
between retinal progenitor cells and lens epithelial cells. XSiah2 overexpression suppressed the 
transcription of Snail-1 and ESR-1 mRNAs at st. 30. These genes are necessary for the invasion 
of lens placode through the EMT and the differentiation into lens endothelial cells, which serves 
as the progenitors for lens fibers, and is located in the anterior portion of the lens between the 
lens capsule and the lens fibers. Accordingly, xSiah2 might affect Notch signaling in endothelial 
cells. 
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Chapter II 
 
Siah2 regulates the level of Nrf2 escaped from Keap1. 
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II.1 Introduction 
 
Ischemia-reperfusion occurs when blood flow to tissues and organs is disrupted and 
subsequently reintroduced. Rapid reintroduction of oxygen generates reactive oxygen species 
(ROS), leading to the oxidative damage (25). Oxidative damage is implicated in a variety of 
pathophysiological processes, including myocardial infarction, stroke, acute renal failure, and 
post-transplantation injury (26). Antioxidant proteins such as heme oxygenase (HO) play 
important roles in protecting cells from such damage and are induced at the transcriptional level 
in response to electrophiles and oxidative stress (27). The antioxidant response element (ARE) 
is a cis-regulatory element critical to the expression of cytoprotective genes encoding 
antioxidant proteins (28). NF-E2-related factor 2 (Nrf2) is a key transcriptional activator of 
AREs and a central regulator of the induction of antioxidant responsive enzymes such as HO-1 
and NAD(P)H-quinone oxidoreductase-1 (NQO-1) (29,30). 
Under oxidative stress, the liberation of Nrf2 from Kelch-like ECH-associated protein 1 
(Keap1) is required for the activation of AREs (31). Oxidative stress and electrophilic agents 
modify key sulfhydryl groups of Keap1, leading to a conformational change that does not allow 
binding of Keap1 to Nrf2 (32). Under normal conditions, Nrf2 is constantly degraded through 
the ubiquitin-proteasome pathway in a Keap1-mediated manner. Two molecules of Keap1 forms 
a cherry-bob structure to which one molecule of Nrf2 binds via two binding motifs localized in 
the N-terminal region of Nrf2, the Neh2 domain (32). Association of Keap1 with Neh2 causes 
ubiquitination of Nrf2 and subsequent degradation through the proteasome pathway (33). Thus, 
Keap1 maintains steady-state levels of Nrf2 and blocks Nrf2-mediated transcription. 
Several studies indicate that phosphorylation of Nrf2 is an important mechanism for the 
activation of AREs. Stress-mediated cytosolic kinases such as protein kinase C (PKC), 
phosphoinositide 3-kinase (PI3K), and p38 mitogen-activated protein kinase (MAPK) have been 
shown to modify Nrf2 and thereby affect transcription from AREs (34-36). In particular, 
phosphorylation of Nrf2 at serine 40 by PKC liberates Nrf2 from Keap1 (34). It has recently 
been reported that Keap1- and cytosolic kinase-dependent mechanisms work in concert (37). 
It is well known that ischemic hypoxia is accompanied by significant increases in 
cytoplasmic ROS, which are produced by cytosolic enzymes such as xanthine oxygenase (XO) 
and by mitochondrial complex III (38). Hence, oxygen deprivation (hypoxia) before 
reoxygenation is considered an important factor in the generation of ROS.    
HIF-1α is a central transcription factor that plays a major role in protecting cells against 
hypoxic stress (5). Under normal conditions, HIF-1α is regulated by the hydroxylation of its 
proline residues. PHDs are central to this mechanism (6), resulting in the association of HIF-1α 
with pVHL and subsequent proteasomal degradation of HIF-1α (12). Nakayama et al. have 
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reported that while PHDs are inactive under hypoxia, they are active under mild hypoxia and 
that Siah2, which is involved in the degradation of PHDs through the proteasome pathway, 
concomitantly affects HIF-1α accumulation under mild hypoxia (7).  
Siah2 is a potent RING finger E3 ubiquitin ligase that limits its own availability through 
self-ubiquitination and is a known regulator of hypoxia-activated pathways (7,9). Under stress 
and hypoxia, p38 MAPK and akt pathways regulate stabilization and induction of Siah2 (39,40). 
Siah2 binds directly to its substrates, such as the netrin membrane receptor (deleted in colorectal 
cancer; DCC) via AXVXP substrate motifs and initiates their proteasomal degradation (10). 
As an inducer of cytoprotective genes, Nrf2 plays an important role in ROS metabolism. 
Indeed, its regulation under oxidative conditions is well characterized. However, despite the 
involvement of ROS in cell damage during hypoxia of ischemia-reperfusion injury (41), the 
mechanisms of Nrf2 regulation under hypoxia remain unclear. A better understanding of Nrf2 
regulation under hypoxia may lead to improvements in therapy for ischemia-reperfusion injury. 
Thus, in this study, I have investigated mechanisms of Nrf2 regulation under hypoxia. 
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II.2 Materials and methods 
 
Materials and Antibodies 
Fetal bovine serum (FBS), MG132, menadione, and Geneticin (G418) were purchased from 
Sigma (St. Louis, MO); SB203580, LY294002, Calphostin C, Dulbecco’s modified Eagle’s 
medium (DMEM), DMEM/Ham’s F-12, and Enhanced chemi-luminescence (ECL) system  
from Wako (Tokyo, Japan); KOD FX DNA polymerase from TOYOBO (Tokyo, Japan); and 
Gene Porter 2 from Gene Therapy Systems (San Diego, CA). Anti-c-Myc, anti-DYKDDDDK 
(FLAG) tag, and anti-HA monoclonal antibodies were purchased from Wako; antiphosphoserine 
antibody from BD Biosciences (San Jose, CA); antihuman ubiquitin antibody from Enzo Life 
Sciences (Farmingdale, NY); antihuman Siah2 antibody from Santa Cruz Biotechnology (Santa 
Cruz, CA); antihuman -actin antibody from Sigma; and horseradish peroxidase-conjugated 
antirabbit and antimouse IgG antibodies from Bio-Rad (Hercules, CA). The antibodies against 
human HIF-1α, human Keap1 and human Nrf2 were prepared as follows. The full lengths of 
HIF-1α, Keap1, and Nrf2 were ligated into pQE80L vectors (QIAGEN, Hilden, Germany), 
which allow protein expression in E.coli. strains. HIF-1α, Keap1, and Nrf2 proteins were 
expressed in E.coli. DH5α, and then purified using Ni-NTA agarose (QIAGEN). Antibodies 
were raised against HIF-1α, Keap1, and Nrf2 in rabbits by previously described method (16). 
The cross-reactivity of these antibodies was confirmed by each purified HIF-1α, Keap1, and 
Nrf2 proteins. 
 
Isolation of RNA and Quantitative real-time PCR (qRT-PCR) 
Total RNA was extracted from Hep3B cells with Isogen (Nippon gene, Toyama, Japan) 
according to the manufacturer’s instructions. Total RNA was converted to cDNA by reverse 
transcription as follows. A reaction mixture containing 1 μg of RNA and 200 U of reverse 
transcriptase (Thermo Scientific, Waltham, MA) was incubated according to the manufacturer’s 
instructions: 10 min at 25°C followed by 60 min at 42°C, and then 10 min at 70 °C to stop the 
reaction. Quantitative real-time PCR was performed using a Thermal Cycler Dice Real Time 
System Single TP850 (Takara Bio inc., Shiga, Japan). SYBR Primer Ex TagII, 10 pmol of 
forward and reverse primers, and 1 μg of cDNA were mixed, and qRT-PCR was then performed 
according to the manufacturer's instructions. The PCR was carried out at 95°C for 10 s, 
followed by 40 cycles of 95°C for 5 s and 60°C for 20 s. Primers for human HistoneH4 
(GenBank Accession No: NM_003548), human Nrf2 (GenBank accession. No: NM_006164), 
human Siah2 (GenBank accession No: NM_005067), human HO-1 (GenBank accession No: 
NM_002123), and human NQO-1 (GenBank accession No: NM_000903) are shown in Table III. 
Quantification was performed using the second derivative maximum method according to the 
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manufacturer's instructions. Values are expressed relative to the transcription of the 
housekeeping gene Histone H4. 
 
Isolation of human Nrf2, Keap1, and Siah2 
cDNAs of human Nrf2, human Keap1 (GenBank accession No: NM_203500), and human 
Siah2 were amplified by PCR. Forty cycles of PCR (98°C for 10 s, 57°C for 30 s, and 68°C for 2 
min) were performed using the cDNA obtained from reverse transcription of total RNA from 
Hep3B cells as the template, using the KOD FX DNA polymerase and corresponding primer 
pairs. Primer pair shown in Table IV include primers 1 and 2 for pQE80L Nrf2, primers 3 and 4 
for pCMV-myc Nrf2, primers 5 and 6 for pQE80L Keap1, primers 7 and 8 for pCMV-HA Keap1, 
and primers 9 and 10 for Siah2. The cDNA of Nrf2 was digested with the restriction enzymes 
BamHI and KpnI or with SalI and XhoI; it was then ligated into pQE80L (Qiagen, Valencia, CA) 
or pCMV-Myc (Clontech, St.Louis, MO), respectively. The cDNA of Keap1 was digested with 
BamHI and HindIII, and then ligated into pQE80L or pCMV-HA (Clontech), respectively. The 
cDNA of Siah2 was digested with BamHI and EcoRI, and then ligated into pcDNA4 
TO-3×FLAG (Invitorogen, Carlsbad, CA). The cDNA of Myc-Nrf2 was amplified by PCR using 
primers 4 and 11. The plasmid pCMV-Myc containing full length wild type (WT) Nrf2 was used 
as a template. The cDNA of Myc-Nrf2 was digested with BamHI and XhoI, and then ligated into 
pcDNA3.1 (+) (Invitorogen). 
 
Preparation of Nrf2 mutants and shRNAs, and Transfection 
The Nrf2 mutants Nrf293–604, V172A, V172A-P174A, S40N, and S40D were prepared. 
Nrf293–604 lacks the first 92 amino acid residues of Nrf2. In the Nrf2 mutants V172A and 
V172A-P174A, Val and/or Pro residues at the Siah2-binding site (V172 and P174) were 
substituted with Ala residues. In the mutants S40N or S40D, the Ser residue in the PKC 
phosphorylation site (S40) was substituted with Asn or Asp, respectively. The cDNA of 
Nrf293–604 was constructed by amplification of full length WT Nrf2 with primers 4 and 12, 
digestion with restriction enzymes SalI and XhoI, and then ligation into pCMV-Myc. The cDNA 
of Myc-Nrf293–604 was then amplified by PCR using primers 4 and 11. The pCMV-Myc plasmid 
containing Nrf293–604 was used as a template. The cDNAs of V172A, V172A-P174A, S40N, and 
S40D were obtained after two PCR steps. In the first PCR, the nucleotide fragment 1 of V172A 
was amplified using primers 11 and 14, nucleotide fragment 2 of V172A-P174A with primers 11 
and 16, nucleotide fragment 3 of S40N with primers 11 and 18, and nucleotide fragment 4 of 
S40D with primers 11 and 20. Furthermore, the nucleotide fragment 5 of V172A was amplified 
with primers 4 and 13, fragment 6 of V172A-P174A with primers 4 and 15, fragment 7 of S40N 
with primers 4 and 17, and fragment 8 of S40D with primers 4 and 19. The second round of 
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PCR was performed using primers 4 and 11 with fragments 1 and 5 (V172A), fragments 2 and 6 
(V172A-P174A), fragments 3 and 7 (S40N), and fragments 4 and 8 (S40D). The cDNAs of 
Myc-Nrf293–604, V172A, V172A-P174A, S40N, and S40D were digested with BamHI and XhoI, 
and ligated into pcDNA3.1 (+). The primers 11–20 were shown in Table III-IV. For the knock 
down of Keap1, HIF-1α, and Siah2 using shRNA and the MOCK control with GFP shRNA, 
specific target regions of Keap1, HIF-1α, Siah2, and GFP were designated according to a 
previously described procedure (42-45). The sense, antisense, and hairpin loop sequences of 
these were inserted stepwise into the pBAsi-hU6 Neo Vector (Takara Bio Inc.) according to the 
manufacturer’s instructions. The sequences of the inserted nucleotides are shown in Table III-V. 
The DNA sequences of all constructs were confirmed by DNA sequence analysis. Plasmids 
were transfected into cells using Gene PORTER
TM
2 according to the manufacturer’s instructions. 
Transfectants were selected using G418. 
 
Cell cultures and Hypoxic stimulation 
Human hepatic carcinoma Hep3B cells were obtained from the Cell Resource Center for 
Biomedical Research at the Institute of Development, Aging and Cancer of Tohoku University 
(Miyagi, Japan). Human cervix carcinoma HeLa cells and human embryonic kidney HEK293 
cells were generous gifts from Prof. Yamasaki and Prof. Hirai of Kwansei Gakuin University, 
respectively. Hep3B and HeLa cells were grown in DMEM supplemented with 10% FBS, 
penicillin (100 units/ml), and streptomycin (100 μg/ml). HEK293 cells were grown in 
DMEM/Ham’s F-12 supplemented with 10% FBS, penicillin (100 units/ml), and streptomycin 
(100 µg/ml). These cells were incubated at 37°C in 95% air and 5% CO2. To simulate hypoxic 
conditions, the cells were cultured in a multi-gas incubator, APM-30D (Astec, Shizuoka, Japan), 
set to 1% O2 and 5% CO2. 
 
Immunoprecipitation and Western blotting 
Immunoprecipitation experiments and western blotting analysis were performed as described 
previously (46). In the immunoprecipitation experiments, a lysis buffer containing 50 mM 
Tris-HCl (pH 8.0), 150 mM NaCl, 1% Triton X100, and 0.1 μg/mL PMSF; a wash buffer 
containing 50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 0.1% Triton X100; protein-A and 
protein-G sepharoses (GE Healthcare, Little Chalfont, Buckinghamshire, U.K.); and negative 
control mouse or rabbit IgG, anti-c-Myc, anti-FLAG, anti-Siah2, anti-Keap1 or anti-Nrf2 
antibodies were used. For western blotting analysis, anti--actin, anti-Nrf2, anti-Keap1, 
anti-Siah2, anti-HIF-1α, anti-ubiquitin, anti-phosphoserine, anti-c-Myc, anti-HA, or anti-FLAG 
antibodies were used. In this study, -actin was used as a loading control. 
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II.3 Results 
 
Suppression of Nrf2 protein under hypoxia 
Hep3B, HEK293, and HeLa cells were subjected to hypoxia for 3, 6, or 9 h, and changes in 
Nrf2 protein levels were examined (Fig. II-1A). Nrf2 protein was suppressed by hypoxia in the 
Hep3B, HEK 293, and HeLa cells. Similarly, changes in Nrf2 mRNA expression were examined 
(Fig. II-1B) and were found to be unchanged under hypoxia. These results suggest that hypoxia 
affects the stabilization of Nrf2 protein. 
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Contributions of HIF-1α or Keap1 to suppression of Nrf2 
HIF-1α is known to be a central factor in the regulation of hypoxic responses (5). I knocked 
down HIF-1α using shRNA in Hep3B cells, and then measured changes in the levels of Nrf2 
protein (Fig. II-2A). The presence of Nrf2 protein was reduced under hypoxia and was not 
recovered by knockdown of HIF-1α, suggesting that HIF-1α does not contribute to the 
suppression of Nrf2 under hypoxia. 
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As Nrf2 is a well-known substrate for Keap1 (31), its suppression under hypoxia may be 
related to the induction and/or activation of Keap1 following hypoxia. However, in western 
blotting experiments, Keap1 protein levels were not changed by hypoxia (Figs. II-2B and 2C), 
suggesting that hypoxia does not induce Keap1 expression. In Hep3B cells overexpressing 
Keap1, Nrf2 protein levels were reduced under hypoxia (Fig. II-2B), suggesting that Keap1 is 
active even under hypoxia. To investigate the effects of active Keap1 on the stabilization of 
Nrf2, Keap1 was knocked down by shRNA in Hep3B, HEK293, and HeLa cells (Fig. II-2C). As 
a result, Nrf2 protein expression increased under normoxia; however, its suppression under 
hypoxia was not completely recovered by knockdown of Keap1 in any cell lines. Nrf2 binds to 
its repressor Keap1 via the Neh2 domain (32), which is absent in the Myc-Nrf293–604 construct. 
Interestingly, under hypoxia, Myc-Nrf293–604 as well as WT Nrf2 was suppressed (Fig. II-3). 
These results suggest that Keap1 does not contribute to the suppression of Nrf2 under hypoxia. 
Using the proteasome inhibitor MG132, I also showed that suppression of Nrf2 (Figs. II-2A 
and 2C) and Myc-Nrf293–604 (Fig. II-3) is dependent on the proteasome under hypoxia as well as 
normoxia. Hence, I predicted that some unidentified hypoxia-activated E3 ubiquitin ligase may 
be involved in the degradation of Nrf2. 
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Contribution of Siah2 to Nrf2 degradation 
Siah2 is known to be an important regulator of hypoxia-activated pathways and is also 
involved in the degradation of substrates such as PHD3 through the E3 ubiquitin ligase and 
proteasome pathways (7). In this study, hypoxia induced Siah2 expression (Fig. II-4). Thus, I 
investigated the effect of menadione, an inhibitor of Siah2 ubiquitin ligase activity (47), on the 
stabilization of Nrf2. As menadione inhibits both Siah2 and Keap1 activities (42), specific 
inhibition of Siah2 by menadione in Hep3B cells was achieved either by suppression of Keap1 
(Fig. II-5A) or expression of Myc-Nrf293–604 (Fig. II-5B). In the presence of menadione, 
expression of Nrf2 and Myc-Nrf293–604 proteins were recovered, indicating that Siah2 serves as a 
novel regulator of Nrf2. 
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In subsequent experiments, knockdown of Siah2 significantly stabilized endogenous Nrf2 in 
the Hep3B, HEK293, and HeLa cells (Fig. II-6A) and induced the Nrf2-responsive genes HO-1 
and NQO-1 in Hep3B cells (Fig. II-6B). In contrast, when Siah2 was overexpressed in Hep3B 
cells (Fig. II-7), Nrf2 protein levels were significantly decreased. These results provide further 
evidence that Siah2 contributes to the suppression of Nrf2 and suggest that Siah2 blocks 
Nrf2-mediated transcription. 
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Siah2 directly binds to substrates carrying the AXVXP binding motif (10). Interestingly, I 
found a putative Siah2-binding motif, AQVAP, at position 170–174 in Nrf2. To identify the 
importance of this Siah2-binding motif, Nrf2 mutants V172A and V172A-P174A, which 
contain single or double mutations in this putative Siah2-binding motif, respectively, were 
expressed in the Hep3B cells (Fig. II-8). Neither V172A nor V172A-P174A were degraded 
under hypoxia, suggesting that this binding motif is essential for the degradation of Nrf2 by 
Siah2 and confirming that Siah2 directly regulates Nrf2. 
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Direct interaction of Siah2 with Nrf2 
Next, I investigated the direct binding interactions of Siah2 and Nrf2 using 
immunoprecipitation and Myc-Nrf2-, V172A-, or V172A-P174A-expressing Hep3B cells (Fig.  
II-9A). In these experiments, both V172A and Myc-Nrf2 interacted with Siah2, whereas 
V172A-P174A did not. A subsequent reciprocal immunoprecipitation assay also confirmed that 
Siah2 binds to Nrf2 through the abovementioned binding motif. Moreover, in both 
immunoprecipitation and reciprocal immunoprecipitation assays, endogenous Siah2 interacted 
with Nrf2 in WT cells (Fig. II-9B). These data offer further evidence of the Siah2-Nrf2 
interaction. 
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Contribution of the phosphorylation of Nrf2 by PKC to Nrf2 suppression by Siah2 
Hypoxia is involved in the activation of several cytosolic kinases (48), and the 
phosphorylation of Nrf2 at serine residues by stress-related cytosolic kinases is an important 
stabilizer of Nrf2 (34-36). Thus, I investigated if serine residues of Nrf2 are phosphorylated 
under hypoxia (Fig. II-10A). As p38 MAPK, PI3K, and PKC are involved in phosphorylation of 
Nrf2, p38 MAPK inhibitor (SB203580), PI3K inhibitor (LY294002), and PKC inhibitor 
(Calphostin C) were used. While treatment with Calphostin C thoroughly inhibited 
phosphorylation at serine residues of Nrf2 under hypoxia, neither SB203580 nor LY294002 had 
any effect under hypoxia. In addition, hypoxia enhanced the phosphorylation of serine residues 
of Nrf2 by PKC (Fig. II-10B). 
 
 
 
PKC phosphorylates the serine residue of Nrf2 at position 40, leading to the liberation of 
Nrf2 from Keap1 (34). To investigate the relationship between phosphorylation of Nrf2 at 
serine 40 and the stabilization of Nrf2 under hypoxia, Asn and Asp mutants, Myc-S40N and 
Myc-S40D, were prepared to mimic the nonphosphorylated and phosphorylated states, 
respectively (Figs. II-11A and 11B). In these experiments, knockdown of Keap1 stabilized 
Myc-S40N protein under normoxia, while it did not aid recovery of either Myc-S40N or 
Myc-S40D proteins under hypoxia (Fig. II-11A), suggesting that nonphosphorylated Nrf2 at 
serine 40 is a target of Keap1 under normoxia; however, it is not a target of only Keap1 under 
hypoxia. Similarly, while knockdown of Siah2 had little effect under normoxia, it rescued the 
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hypoxic decrease in Myc-S40D protein (Fig. II-11B), suggesting that phosphorylated Nrf2 at 
serine 40 is a target of Siah2 under hypoxia. To further examine the effect of PKC-mediated 
phosphorylation of Nrf2 on the degradation of Nrf2 by Keap1, Keap1 knockdown Hep3B cells 
were grown in the presence of Calphostin C (Fig. II-11C). Under hypoxia, Nrf2 protein, which 
was not subject to the phosphorylation by PKC, was not completely recovered by Calphostin C 
in these cells, further suggesting that nonphosphorylated Nrf2 is degraded by additional factors 
to Keap1 under hypoxia. Similarly, to evaluate if PKC-mediated phosphorylation of Nrf2 
contributes to the degradation of Nrf2 by Siah2, Siah2 knockdown Hep3B cells were grown in 
the presence of Calphostin C (Fig. II-11D). In these cells, Nrf2 protein levels were decreased, 
suggesting that after phosphorylation by PKC, Nrf2 is subject to Siah2-mediated degradation. 
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Contribution of Siah2 to the degradation and ubiquitination of nonphosphorylated Nrf2  
Myc-Nrf293–604 lacks the Neh2 domain, which includes the phosphorylation site at serine 40; 
however, the treatment with either MG132 or menadione led to recovery of its expression (Figs. 
II-3 and 5B), as described above. Moreover, my results proposed that nonphosphorylated Nrf2 
is degraded by additional factors to Keap1 under hypoxia (Figs. II-11A and 11C). Hence, I 
predicted that Siah2 may be involved in the degradation of not only phosphorylated Nrf2 but 
also nonphosphorylated Nrf2. To identify the importance of phosphorylation site in Neh2 
domain under hypoxia, Myc-Nrf2 or Myc-Nrf293–604 was expressed in Siah2 knockdown Hep3B 
cells (Fig. II-12A). Hypoxic decreases in Myc-Nrf293–604 and Myc-Nrf2 were prevented in the 
Siah2 knockdown cells. Moreover, in both immunoprecipitation and reciprocal 
immunoprecipitation assays, Myc-Nrf293–604 as well as Myc-Nrf2 interacted with Siah2 (Fig. 
II-12B), suggesting that the phosphorylation site is not required for the degradation of Nrf2 by 
Siah2 or the interaction between Siah2 and Nrf2. Importantly, although Nrf2 phosphorylated by 
PKC is subject to Siah2-mediated degradation, Siah2 as well as Keap1 contributes to the 
degradation of nonphosphorylated Nrf2. 
In a Keap1-mediated manner, Neh2 is ubiquitinated, and then Nrf2 is degraded through the 
proteasome pathway (33). I analyzed the ubiquitination and degradation of Myc-Nrf293–604 in the 
presence and absence of MG132 (Fig. II-12C). Most of Myc-Nrf293–604 got ubiquitinated, and 
knockdown of Siah2 attenuated this ubiquitination of Myc-Nrf293–604, suggesting that 
association of Siah2 with Nrf2 causes ubiquitination of Nrf2 and subsequent degradation 
through the proteasome pathway. 
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Significance of the phosphorylation of Nrf2 
To investigate interactions of phosphorylated Nrf2 with Keap1 and Siah2, Hep3B cells were 
grown in the presence of Calphostin C, and immunoprecipitation was performed (Figs. II-13A 
and 13B). The interaction between Siah2 and Nrf2 was attenuated by treatment of Calphostin C, 
whereas the interaction between Keap1 and Nrf2 was enhanced (Fig. II-13A). In addition, the 
interaction between Siah2 and phosphorylated Nrf2 was attenuated by treatments with 
Calphostin C (Fig. II-13B). These results suggest that PKC-mediated phosphorylation of Nrf2 is 
required for the escape of Nrf2 from Keap1, resulting in the association of Nrf2 with Siah2. 
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II.4 Discussion 
Ischemia-reperfusion generates ROS and leads to cellular damage and oxidative stress in 
hypoxia and subsequent reoxygenation (25). While this mechanism is accepted for 
reoxygenation, the association of cellular damage with hypoxia-ischemia is not as well known. 
Three major sources of ROS, including mitochondria, XO, and Ca
2+ 
flux, are activated during 
ischemic hypoxia, representing an important mechanism of cytotoxicity (38). ROS causes lipid 
peroxidation as well as protein and DNA oxidation (25), and also stimulates ischemic cells to 
secrete inflammatory cytokines and chemokines, that induce cell damage (49). Cellular 
oxidative stress defense systems are tightly regulated through synthesis and degradation of 
many transcription factors such as Nrf2 and HIF-1α. Although the generation of ROS under 
hypoxia causes cellular injury, the regulation of Nrf2 in hypoxia has been investigated. 
Hypoxia suppresses the stabilization of Nrf2 and enhances that of HIF-1α. HIF-1α plays a 
central role in the regulation of hypoxic responses (5). The previous study showed that a partner 
of Nrf2, Maf G, binds to HIF-1α and leads to transcription from hypoxia-responsive elements 
(HREs) (50). Indeed, the induction of HIF-1α might prevent interactions of Maf G with Nrf2, 
leading to the hypoxic suppression of Nrf2. However, knockdown of HIF-1α did not recover 
hypoxic suppression of Nrf2, suggesting that HIF-1α does not suppress Nrf2. 
As a transcription factor, Nrf2 binds to AREs and induces variety of genes that encode 
cytoprotective enzymes such as HO-1 and NQO-1 (29,30). These defense enzymes play critical 
roles in protecting cells from cellular degeneration. Under stressful conditions, Nrf2 is 
upregulated and activates AREs. In these conditions, a conformational change in Keap1 and/or 
phosphorylation of Nrf2 by stress-related cytosolic kinases prevents binding of Keap1 to Nrf2, 
wherein Nrf2 is available for ARE binding and induces cytoprotective genes. Similarly, under 
hypoxia, HREs are activated and cytoprotective genes are induced (51). In this study, hypoxia 
significantly suppressed accumulation of Nrf2. Conversely, overexpression of Nrf2 suppressed 
the activation of HREs by hypoxia, suggesting that suppression of Nrf2 is required for full 
activation of HREs. 
In this study, I have defined a novel Nrf2 regulatory pathway. My results show that 
hypoxia-activated E3 ubiquitin ligase Siah2 regulates both nonphosphorylated Nrf2 and Nrf2 
phosphorylated by stress-related kinase PKC, which is activated by hypoxia. The biological 
significance of my findings is best illustrated by the abundance of Nrf2 in hypoxia in Siah2 
knockdown cells compared with that in Keap1 knockdown cells. 
Importantly, while Myc-Nrf293–604 lacks the phosphorylation site at serine 40, and it was 
recovered by inhibition or knockdown of Siah2. Moreover, under normoxia, phosphorylated 
Nrf2 was barely observed and Nrf2 accumulation was decreased by overexpressing of Siah2 
even under normoxia. Furthermore, Myc-S40N was still degraded in Keap1 knockdown cells, 
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confirming that Siah2 binds and degrades both phosphorylated and nonphosphorylated Nrf2. 
In a Keap1-medated manner, Neh2 domain is required for the ubiquitination of Nrf2, because 
Neh2 domain includes Keap1 binding site and lysines for ubiquitin attachment; however, my 
results showed that Neh2 domain is not required for the ubiquitination of Nrf2, suggesting that 
in the degradation of Nrf2, Siah2-mediated manner is different from that of Keap1. It means that 
Neh domains except Neh2 domain include a novel site for ubiquitination. Indeed, the domains 
includes Siah2 binding site. 
Previous investigations have established that Nrf2 is degraded in response to stress by the 
Keap1/Cullin3 complexes (33) and that phosphorylation of Nrf2 leads to dissociation from 
Keap1 (34). Under hypoxia and other stress conditions, p38 MAPK and akt pathways regulate 
stabilization and induction of Siah2 (39,40). In agreement, the present data suggest that while 
the Keap1 complex limits the expression of Nrf2, Siah2 limits the expression of Nrf2 before 
recruitment and/or after liberation from Keap1. 
Given that the activity of Siah2 is inhibited in proportion to increasing oxygen concentration 
(52), I investigated its significance to the degradation of Nrf2 under hypoxia. Under mild 
hypoxia, Siah2-mediated degradation of Nrf2 is attenuated, leading to an abundance of Nrf2. 
Under these conditions, ROS are likely to be generated, and activation of Nrf2 is required for 
protection from oxidative stress. In contrast, severe hypoxia is not associated with ROS because 
too few oxygen molecules are available to generate hydrogen peroxide or super oxide. These 
conditions lead to the maintenance of active Keap1, although PKC continues to phosphorylate 
Nrf2 and cause dissociation from Keap1. I propose that Siah2-mediated degradation of 
phosphorylated Nrf2 is of physiological importance, as a mechanism that prevents excess 
activation of AREs by Nrf2 and blocks Nrf2-mediated transcription of target genes. 
In this study, experiments were predominantly performed in Hep3B, HEK293, and HeLa cells. 
Importantly, the interaction of Siah2 with Nrf2 was observed in all these cell lines, suggesting 
that Siah2 contributes to the accumulation of Nrf2 ubiquitously. However, the effects of Keap1 
knockdown on the accumulation of Nrf2 under hypoxia differed between cells types. Indeed, 
knockdown of Keap1 facilitated Nrf2 recovery in the Hep3B and HEK293 cells but only 
partially in the HeLa cells. Hence, I predicted that the sensitivity, accumulation, and activities of 
cytosolic kinase-related pathways, especially PKC, may also differ between these cell types. 
Given that Siah2 regulates the abundance of HIF-1α by degrading PHD3 (9), it may be 
involved in the regulation of hypoxia-induced ROS. My results demonstrate that inhibition or 
knockdown of Siah2 causes suppression of HIF-1α and increases Nrf2. Hence, I proposed that 
the inhibition of Siah2 may be followed by inactivation of HIF-1α-mediated pathways and 
activation of Nrf2-mediated pathways, leading to attenuated ROS production. Therefore, Siah2 
may be a novel target for ROS metabolites. This study provides clues for understanding for 
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therapeutic approaches to pathological states caused by ischemia-reperfusion injury.  
In summary, my study demonstrates that hypoxia induces the phosphorylation of Nrf2 by 
PKC, and thus decreases Keap1-mediated degradation compared with that under normoxia. 
Moreover, concomitant stabilization of Siah2 protein provides a dominating Nrf2 degradation 
pathway over that of Keap1 under hypoxia, leading to hypoxic suppression of Nrf2 by Siah2.
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General conclusions and perspectives 
In the present study, I showed that Siah2-mediated availability of HIF-1 contributes to lens 
formation during the embryonic development of Xenopus laevis. Distinct from earlier reports 
that the HIF-1systemis involved in angiogenesis (11), my findings supports its involvement 
in neurogenesis of vertebrates, and further indicate that hypoxic conditions play an important 
role in the development of vertebrate animals. 
Another major finding was that Siah2 contributes to regulation of Nrf2, irrespective of its 
phosphorylation status. The collective results suggest Siah2-mediated cross-talk between the 
Nrf2 and HIF-1 pathways, signifying that Siah2 regulates the accumulation of both Nrf2 and 
HIF-1. 
HIF-1 facilitates the induction of ROS producing enzymes, such as NADPH oxidase (53), 
whereas Nrf2 contributes to the induction of phase II enzymes. Hypoxia-mediated suppression 
of Nrf2 and increase in HIF-1 may trigger excessive ROS production under reoxygenation 
conditions. Accordingly, modulation of Siah2 activity is proposed to reduce oxidative injury of 
organs under ischemia-reperfusion. 
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Table I-1 
 
Primers GenBank accession No., cycles, and sequences for PCR. 
Factor Accession No. cycles Sequences 
HistoneH4 
 
M21286 24 forward:5’-CAGGAGATGGCCACAGCTGC-3’ 
reverse: 5’-TCTTTCTGCATTCTATCAGCA-3’ 
FoxE3 
 
BC169818 24 forward:5’-CCTCTGGAGGCAGGAGAAGA-3’ 
reverse:5’-TCTGAGGGTTATATCCAGAGCC-3’ 
β-crystallin 
 
BC084735 24 forward:5’-TGCCTGGAGTGGAACAATGC-3’ 
reverse:5’-TGTTGAACCATCCCATATGC-3’ 
Snail-1 BC056857 28 forward:5’-CAGCAAGTCTTACTCCACCT-3’ 
reverse:5’-CTCCTGTGTGTGTTCTGATG-3’ 
N-cadherin X57675 27 forward:5’-ATGGCGATGGAATTGTATGT-3’ 
reverse: 5’-GAAGACACCGAGTGGAGGTT-3’ 
ESR-1 AF383157 31 forward:5’-ACAAGCAGGAACCCAATGTC-3’ 
reverse:5’-GCCAGAGCTGATTGTTTGGA-3’ 
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Table I-2 
 
Primers number and sequences for isolation of xSiah2 
Factor Primer number Sequences 
xSiah2 primer 1 
primer 2 
primer 3 
primer 4 
primer 5 
GACTAGTGTAATCAATGCCGCCAGAAG 
TAGGATCCTTCGTGTGCCGATTAGGAG 
TACTAGTGCGATGAGCCGCCC 
CGAATTCTTATGGACAACATGTGGAAATGG 
GCGAAGCTTTCAGTGCTGCATAACATTTTC 
Underline: Restriction enzyme site; Double underline: Start or Stop codon 
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Table II-1 
 
Primers for quantitative real-time PCR 
Factor forward/ 
reverse 
Sequence 
Histone H4 forward CCG CAA GGT CTT GAG AGA CAA A 
 reverse CTA GCC TCC GAA GCC GTA CA 
Nrf2 forward CGG TAT GCA ACA GGA CAT TG 
 reverse AGG ATG CTG CTG AAG GAA TC 
Siah2 forward ACC TGG CTA TGG AGA AGG TG 
 reverse CAC ACC GTC ATG AAT CGA AC 
HO-1 forward CCA GCC ATG CAG CAC TAT GT 
 reverse AGC CCT ACA GCA ACT GTC GC 
NQO-1 forward TGA TCG TAC TGG CTC ACT CA 
 reverse GTC AGT TGA GGT TCT AAG AC 
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Table II-2 
 
Primers for cloning human Nrf2, Keap1, and Siah2; and for construction of Nrf2 mutants 
Factor Primer number Sequence 
Nrf2 1 AAG GAT CCA TCA TGA TGG ACT TGG AGC T 
 2 AAG GTA CCA TTC AAC ATA CTG ACA CTC C 
 3 ATA GTC GAC CAT GAT GGA CTT GGA GC 
 4 AGA CTC GAG AAC ATA CTG ACA CTC CAA TG 
Keap1 5 ATG GAT CCC CCA TGC AGC CAG ATC CCA G 
 6 TTA AGC TTA ATC AAC AGG TAC AGT TCT GCT 
 7 ATTA AGC TTC CCA TGC AGC CAG ATC C 
 8 CTG GAT CCT CAA CAG GTA CAG TTC TG 
Siah2 9 ATG GAT CCG CGA TGA GCC GC 
 10 GCG GAA TTC GAA AGT CAC ATC ATG GAC 
pCMV 11 CAG GAT CCA TGG CAT CAA TGC AGA AG 
Nrf293-604 12 ATA GTC GAC CCA GTC AGA AAC CAG TG 
V172A 13 TCT GTT GCT CAG GCA GCC CCT GTT GAT TTA 
 14 TAA ATC AAC AGG GGC TGC CTG AGC AAC AGA 
V172A-P174A 15 GTT GCT CAG GCA GCC GCT GTT GAT TTA GAC 
 16 GTC TAA ATC AAC AGC GGC TGC CTG AGC AAC 
S40N 17 GAG AAG TAT TTG ACT TCA ATC AGC GAC GGA 
 18 TCC GTC GCT GAT TGA AGT CAA ATA CTT CTC 
S40D 19 GAG AAG TAT TTG ACT TCG ATC AGC GAC GGA 
 20 TCC GTC GCT GAT CGA AGT CAA ATA CTT CTC 
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Table II-3 
 
Nucleotides for Keap1, HIF-1α, Siah2, and GFP shRNAs 
Factor Sequence Reference 
Keap1 GCA GGC CTT TGG CAT CAT GAA CGT GTG CTG TCC GTT 
CAT GAT GCC AAA GGC CTG CTT TTT T 
(43) 
Siah2 ACC CGG AGT GCT TAT CTT AAA CTG TGA AGC CAC AGA 
TGG GTT TAA GAT AAG CAC TCC GGG TTT TTT T 
(44) 
HIF-1α GCA ACT GTC ATA TAT AAC ACC CCC CTG TGA AGC CAC 
AGA TGG GGG GGG TGT TAT ATA TGA CAG TTG CTT TTT T 
(45) 
GFP GTA CAG GAA CGC ACT ATA TCT CTG TGA AGC CAC AGA 
TGG GAG ATA TAG TGC GTT CCT GTA CTT TTT T 
(46) 
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